Medical Biochemistry

Uzm. Dr. Hacer Eroğlu İçli

Doctor and researcher Bakırköy Prof. Dr. Mazhar Osman Ruh Sağlığı ve Sinir Hastalıkları E. A. H. İstanbul
Rhinitis, Allergic, Perennial
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Rhinitis, Allergic, Perennial 2 publications
    Source: OpenAlex / PubMed MeSHView publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Biochemistrysaglik.gov.trFrom source
  • Department name at the sourceBiyokimya ve Klinik Biyokimyasaglik.gov.trFrom source
  • InstitutionBakırköy Prof. Dr. Mazhar Osman Ruh Sağlığı ve Sinir Hastalıkları E. A. H.saglik.gov.trFrom source
  • Area of workRhinitis, Allergic, PerennialExtracted from 2 publications · Model version —From source
  • Publications24 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0002-9775-1710ORCIDFrom source
  • Last synchronised5 November 2026 08:55https://bakirkoyruhsinireah.saglik.gov.tr/TR-1573388/doktorlarimiz.html#hacer-eroglu-iclisaglik.gov.tr

Scientific work

Publications on Rhinitis, Allergic, Perennial

24 publications

  1. The Effect of Methylphenidate Treatment on Oxidative Stress Levels in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder: An Observational Study

    Journal of Child and Adolescent Psychopharmacology, 2026

    DOI 10.1177/10445463261436792 PMID 41873451 1 citation (OpenAlex) Source: ORCID

  2. Inflammatory Markers in Obsessive-compulsive Disorder: The Role of Childhood Trauma

    Clinical Psychopharmacology and Neuroscience, 2026

    DOI 10.9758/cpn.26.1444 Open-access full textSource: ORCID

  3. Cardiovascular Risk in Methamphetamine Use Disorder: Longitudinal Changes in Oxidative Stress and Atherogenic Lipid Profiles During Early Remission

    Bratislava Medical Journal, 2026

    DOI 10.1007/s44411-026-00606-1 Source: ORCID

  4. Metabolite-targeted LC-HRMS quantification of emerging indazole-based synthetic cannabinoids in urine samples from an addiction treatment cohort

    Journal of Chromatography B, 2026

    DOI 10.1016/j.jchromb.2026.125320 PMID 42843294 Source: ORCID

  5. Kynurenine Pathway Metabolites and Executive Function Impairments in Generalized Anxiety Disorder: A Case Control Study

    Psychiatric Quarterly, 2025

    DOI 10.1007/s11126-025-10241-8 PMID 41247643 2 citations (Europe PMC) Source: ORCID

  6. The Evaluation of Serum Total Tau, NFL, Neurogranin, YKL-40, and FABP-3 as Screening Biomarkers for Alzheimer's Disease

    Experimed, 2025

    DOI 10.26650/experimed.1587358 1 citation (OpenAlex) Open-access full textSource: ORCID

  7. The relationship between kynurenine metabolites and executive functions in patients with generalized anxiety disorder

    European Psychiatry, 2025

    DOI 10.1192/j.eurpsy.2025.272 Open-access full textSource: OpenAlex

  8. 1. Uluslararası Katılımlı Adli ve Klinik Toksikoloji Günleri Özet ve Bildiri Kitabı I. International Participation on Forensic and Clinical Toxicology 'Addiction Psychiatry'

    Zenodo (CERN European Organization for Nuclear Research), 2025

    DOI 10.5281/zenodo.17580926 Open-access full textSource: OpenAlex

  9. Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis

    Biomedicines, 2024

    DOI 10.3390/biomedicines13010040 PMID 39857624 3 citations (Europe PMC) Open-access full textSource: ORCID

  10. Combined Serum Total Tau-Neurofilament Light Polypeptide Could be Used as Screening Biomarkers For Alzheimer’s Disease

    Research Square, 2024

    DOI 10.21203/rs.3.rs-4761789/v1 Open-access full textSource: ORCID

View all 24 publications